FoodPack Tanzania 2025
Organizer:
International Society for Pharmaceutical Engineering - ISPE
Duration:
TBD
Venue:
TBD
Location:
United States
Website:
Industry Focus:
Introduction:
The ISPE Facilities of the Future Conference will explore advancements in pharmaceutical technology and what pharmaceutical manufacturing facilities will look like in the future. Featuring technical and inspirational presentations and case-studies from industry leaders already planning and building 'facilities of the future'.
This conference will look at new manufacturing advances, the challenges, innovative technologies, and regulatory factors impacting the adeptness of today's pharmaceutical companies to stay competitive and cost-effective. Speed to patient is repeatedly a key requirement in project delivery and COVID-19 accelerated many trends and collaborations. Considering the lessons learnt from the pandemic, transformations and updates in facility design and project execution approaches, as necessary elements, will be presented.
During the conference, we will look at the maturation of the biopharmaceutical industry. Regulatory agencies have matured along with the biopharmaceutical industry, and we expect programs for cell and gene therapies to advance in the next few years. Emphasis will be on bio manufacturing with process control and automation, workforce of the future with the right expertise, and scaling-up.
Both new and legacy pharmaceutical facilities will be featured in our conference, with a focus on efficiency and cGMP compliancy, while adopting emerging technologies to improve drug quality. The impact of disruptive technologies and Pharma 4.0, highly automated processes using the Internet of Things (IoT), Artificial Intelligence (AI), robotics, advanced analytics, the use of digital twins, and machine learning will be covered. Additionally, facility designs that embrace the attributes of facilities of the future such as adaptability and flexibility will be included, with a particular emphasis on single-use, regenerative medicines, and drug product facilities.